Lung cancer drug under the microscope: how does cemiplimab perform in real life?
NCT ID NCT05363319
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study follows 500 European patients with advanced non-small cell lung cancer who are already prescribed cemiplimab (Libtayo) as part of their normal care. Researchers will track how long patients live, how well the cancer responds, and any side effects. The goal is to see if the drug works as well in everyday clinics as it did in earlier clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cemiplimab (Libtayo) with or without platinum-based chemotherapy
- What this could lead to
- If successful, this study could confirm that cemiplimab works well in everyday clinical practice, not just in controlled trials, for advanced lung cancer.
- What could go wrong
- This is an observational study, not a controlled experiment, so results may be less reliable. It only looks at patients already prescribed the drug, so it cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AO Universitaria Policlinico Vittorio Emanuele
RECRUITINGCatania, 95123, Italy
-
AORN dei Colli
RECRUITINGNaples, 80131, Italy
-
AOU Careggi
RECRUITINGFlorence, Firenze, 50134, Italy
-
APHM - Hopital Nord
RECRUITINGMarseille, Bouches-du-Rhône, 13915, France
-
Agaplesion Diakonieklinikum Rotenburg
RECRUITINGRotenburg (Wümme), Lower Saxony, 27356, Germany
-
Azienda Ospedaliero-Universitaria di Modena
RECRUITINGModena, 41124, Italy
-
Azienda Sanitaria Locale (ASL) Taranto
RECRUITINGTaranto, 74010, Italy
-
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) Santa Maria della Misericordia
RECRUITINGUdine, 33100, Italy
-
Center Hospitalier Universitaire (CHU) of Clermont
COMPLETEDClermont-Ferrand, 63003, France
-
Centre Hospitalier - Le mans
RECRUITINGLe Mans, 72037, France
-
Centre Hospitalier Universitaire (CHU) de Poitiers
RECRUITINGPoitiers, Vienne, 86021, France
-
Centre Hospitalier Universitaire Angers
RECRUITINGAngers, 49000, France
-
Complejo Hospitalario Universitario de Ferrol - Hospital Naval
RECRUITINGFerrol, Galicia, 15405, Spain
-
Consorcio Hospitalario Provincial de Castellon
RECRUITINGCastellon, Castellon, 12002, Spain
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, 20133, Italy
-
Fondazione IRCCS Policlinico San Matteo
RECRUITINGPavia, 27100, Italy
-
Franziskus Hospital Harderberg
RECRUITINGGeorgsmarienhütte, Georgsmarienhuette, 49124, Germany
-
Gemeinschaftskrankenhaus Havelhoehe
RECRUITINGBerlin, 14089, Germany
-
Gesellschaft fur Onkologische Studien Dortmund mbH (Gefos)
RECRUITINGDortmund, 44263, Germany
-
Haematologisch Onkologische Schwerpunktpraxis - Troisdorf
RECRUITINGTroisdorf, North Rhine-Westphalia, 53840, Germany
-
Hopital Tenon
RECRUITINGParis, 75020, France
-
Hopitaux Universitaires de Strasbourg
RECRUITINGStrasbourg, Bas-Rhin, 67000, France
-
Hospital Arnau de Vilanova
RECRUITINGLleida, 25198, Spain
-
Hospital Torrecardenas
RECRUITINGAlmería, 04009, Spain
-
Hospital Universitari Sant Joan de Reus
RECRUITINGTarragona, 43204, Spain
-
Hospital Universitario Alvaro Cunqueiro
RECRUITINGVigo, Galicia, 36204, Spain
-
Hospital Universitario De Jerez
RECRUITINGJerez de la Frontera, Cadiz, 11407, Spain
-
Hospital Universitario Nuestra Senora de Candelaria
RECRUITINGSanta Cruz de Tenerife, 38010, Spain
-
Hospital Universitario Virgen De La Victoria Malaga
RECRUITINGMálaga, Andalusia, 29010, Spain
-
Humanitas Istituto Clinico Catanese
RECRUITINGMisterbianco, Catania, 95065, Italy
-
IRCCS Humanitas Research Hospital
RECRUITINGRozzano, Milan, 20089, Italy
-
Istituto Nazionale Tumori IRCCS Fondazione G Pascale
RECRUITINGNaples, 80131, Italy
-
Klinikum Chemnitz gGmbH
WITHDRAWNChemnitz, Saxony, 09116, Germany
-
Klinikum Klagenfurt
RECRUITINGKlagenfurt, Carinthia, 9020, Austria
-
Klinikum Konstanz
RECRUITINGKonstanz, Baden-Wurttemberg, 78464, Germany
-
Krankenhaus Martha-Maria Halle-Doelau gGmbH
RECRUITINGHalle, 06120, Germany
-
Le Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Emile Muller Hospital
RECRUITINGMulhouse, Alsace, 68100, France
-
Marienhaus Klinikum Mainz
WITHDRAWNMainz, 55131, Germany
-
MedFISMO
WITHDRAWNWeinsberg, Baden-Wurttemberg, 74189, Germany
-
Nuremberg Hospital, Campus North
COMPLETEDNuremberg, Bavaria, 90419, Germany
-
Ospedale Di Cisanello Azienda Ospedaliero Universitaria
RECRUITINGPisa, Tuscany, 56126, Italy
-
Parc Tauli Sabadell Hospital Universitari
RECRUITINGSabadell, Barcelona, 08208, Spain
-
Pneumologische Praxis PD Dr. Med Christian Gessner
RECRUITINGLeipzig, Saxony, 4347, Germany
-
Sainte Catherine Institut du Cancer Avignon Provence
RECRUITINGAvignon, Vaucluse, 84918, France
-
Salzburger Landeskliniken (SALK)
RECRUITINGSalzburg, 5020, Austria
-
San Luigi Gonzaga University Hospital
RECRUITINGOrbassano, Piedmont, 10043, Italy
-
St. Franziskus Hospital Münster
RECRUITINGMünster, North Rhine-Westphalia, 48145, Germany
-
Staedtisches Klinikum Muenchen Bogenhausen
RECRUITINGMünchen, Bavaria, 81925, Germany
-
University Hospital of Jaen
RECRUITINGJaén, 23007, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?